1995
DOI: 10.1097/00132586-199512000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Ketamine Inhibits Glutamate-, N-Methyl-D-Aspartate-, and Quisqualate-Stimulated cGMP Production in Cultured Cerebral Neurons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
8

Year Published

1997
1997
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(20 citation statements)
references
References 0 publications
0
12
0
8
Order By: Relevance
“…This study provides in vitro data that directly show the suppressive effects of ketamine on NO production in HUVECs. In cultured cerebral neurons, Gonzales et al reported that N-methyl-Daspartate-and non-N-methyl-D-aspartate-specific analogs increased NO synthesis, but ketamine reduced this effect (29). Ketamine has been reported to reduce NO production in lipopolysaccharide-activated macrophages (30).…”
Section: Discussionmentioning
confidence: 99%
“…This study provides in vitro data that directly show the suppressive effects of ketamine on NO production in HUVECs. In cultured cerebral neurons, Gonzales et al reported that N-methyl-Daspartate-and non-N-methyl-D-aspartate-specific analogs increased NO synthesis, but ketamine reduced this effect (29). Ketamine has been reported to reduce NO production in lipopolysaccharide-activated macrophages (30).…”
Section: Discussionmentioning
confidence: 99%
“…Regarding the different effect of ether and ketamine on the acrophases of T, H and A, the effect of ketamine could be interpreted according to its mechanisms of action. The glutamatergic neurotransmission is involved in the hypnotic activity of ketamine as shown in vivo (Yamamura et al 1990) or in vitro (Gonzales et al 1995) by inhibition of the excitatory amino acid (NMDA) receptors' activity. Elsewhere, monoaminergic neurotransmission is also concerned by ketamine since this drug has been shown to inhibit synaptic norepinephrine re-uptake (Cook et al 1991).…”
Section: Discussionmentioning
confidence: 99%
“…Although stimulation of NOS with the subsequent production of NO triggered by activation of NMDA receptors plays an important role in the spinal nociceptive processing of information (see Introduction), there are other receptor systems that can also activate the NO pathway. For instance, activation of glutamate receptors other than NMDA receptors can also increase cGMP concentrations in spinal cord slices from neonate rats (Morris et al, 1994) and in cultured cerebellar cortical neurones from fetal rats (Gonzales et al, 1999). In both cases, NOS inhibitors, including L-NAME, blocked the increase in cGMP concentrations (Morris et al, 1994;Gonzales et al, 1999).…”
Section: Ketamine and Ketoprofen Combinationmentioning
confidence: 99%